Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency

Area of Science:

• Pediatric Hematology
• Immunology
• Transplantation Medicine

Background:

• Hematopoietic cell transplantation (HCT) is a curative option for pediatric primary immunodeficiencies (PID).
• Conventional myeloablative conditioning causes significant toxicities and long-term effects.
• There is a need for safer conditioning strategies in HCT for PID.

Purpose of the Study:

• To review recent advancements in conditioning regimens for HCT in children with PID.
• To evaluate transplant outcomes associated with reduced toxicity conditioning (RTC) regimens.
• To highlight emerging strategies and their impact on PID treatment.

Main Methods:

• Review of current literature on conditioning regimens for HCT in PID.
• Analysis of transplant outcomes data for RTC regimens.
• Focus on newer agents like treosulfan and stem cell sources.

Main Results:

• Reduced toxicity conditioning regimens have significantly improved HCT outcomes in PID.
• Treosulfan shows promise as a preparative agent.
• Peripheral stem cell sources are linked to better donor chimerism with RTC.
• Minimal conditioning regimens with monoclonal antibodies show promising early results.

Conclusions:

• Reduced toxicity conditioning is now the standard of care for PID HCT.
• RTC regimens improve transplant survival, especially for patients with comorbidities.
• Advancements in conditioning have reduced transplant-related mortality and late effects.